Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Nabilone is a synthetic cannabinoid with therapeutic use as an antiemetic and as an adjunct analgesic for neuropathic pain. It is a synthetic cannabinoid, which mimics the main ingredient of marijuana (THC). Chemically, nabilone is similar to the active ingredient found in naturally occurring Cannabis sativa L. Nabilone is not listed as a narcotic by WHO as it lacks the euphoric and recreational potential of other cannabinoids.

In Canada, the United States, the United Kingdom and Mexico, nabilone is marketed as Cesamet. It was approved in 1985 by the U.S. Food and Drug Administration (FDA) for treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics. Though it was approved by the FDA in 1985, the drug only began marketing in the United States in 2006. It is also approved for use in treatment of anorexia and weight loss in patients with AIDS.

Although it doesn't have the official indication (except in Mexico), nabilone is widely used as an adjunct therapy for chronic pain management. Numerous trials and case studies have demonstrated various benefits for condition such as fibromyalgia and multiple sclerosis.

More on Wikipedia

Brand name: Cesamet
Generic name/category: Nabilone, antiemetic
Company: Valeant
Country/Market: Canada, North America
Indication(s)/use: chemotherapy-induced nausea and vomiting
Target: Healthcare Professionals (HCP)
Medium: Web banner
Size/duration: 728X90
Publication/Aired: NEJM – September 2009

To see all of this brand's ads on AdPharm, click here
0 views
Sep 03, 2009

Visit AdPharm.net for more pharmaceutical ads

Go around the world without the world moving you around.

Dimenhydrinate (marketed under brand names Dramamine, Gravol, and Vertirosan) is an over-the-counter drug used to prevent nausea and motion sickness. It is marketed in Portugal as Viabom, but in prescription format. – Wikipedia

Agency: JWT, Venezuela
Photographer: Claudio Napolitano
2009

For up to 80% of surgery patients, the risk of PONV doesn’t stop when recovery starts.

When your patients’ postoperative nausea and vomiting won’t come to a full and complete stop, it’s no fun for you either. Don’t let PONV problems take your practice along the ride.

Find out more at www.NoFunForAnyone.com

MGI Pharma. Healthy Curiosity.

Agency: GSW Worldwide
Creative Director-copy: Kris Early
Art Director: Eric Davis And Dean Barrett
Copywriter: Kurt Richards And Pat Etter
Photographer: Gary Simpson
RXClub 2008 Silver Award Winner

More nausea ads and RxClub award winners on AdPharm

Yup, you’re covered.

Agency: Publicis, New York
Chief Creative Director: Rob Feakins
Group Creative Director: Bertrand Garbassi
Art Director: John Wagner
Copywriter: Dan Cohen
Print Production Manager: Kristan Gabriel
Retoucher: James Du

Via Coloribus